William Aliski, Director at Ultragenyx Pharmaceutical Inc. (RARE), sold 6,000 shares at $78.70 ($469K) on 2016-12-05, disclosed to the SEC on 2016-12-05.
Open-market sale of $469k RARE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $77.94 | 4,000 | $312K | 66.5% |
| 2 | $78.70 | 2,000 | $157K | 33.5% |
| Total | $78.19 avg | 6,000 | $469K | 100% |
| Filing → |
| RARE | SELL | 2020-06-03 | $1.5M | — | Filing → |
| RARE | SELL | 2020-05-20 | $560K | — | Filing → |
| AGTC | BUY | 2018-12-18 | $19K | — | Filing → |